Leukaemia
Assessing the effectiveness and safety of Venetoclax (a type of targeted therapy medicine) combination therapy in children with Acute Myeloid Leukemia (a common type of blood cancer).
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyStudy of how care is given
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial HospitalMumbaiDirections ↗
Registry summary (technical)
Evaluation of Venetoclax-Based Combination Therapies in Childhood Acute MyeloidLeukemia: A Phase II Randomized Controlled Trial - NIL
Sponsor: Dr Shyam Srinivasan
CTRI/2025/12/098296 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 14 Sep 2026 · read by us 5 Nov 2026